Dr. Dabbagh has spent more than two decades in biotech and pharma leadership, specializing in I&I. He joins Dualitas from Silver Creek Pharmaceuticals, where he was President and CEO. Prior to that, he served as President and CEO of Second Genome, helping build the company’s R&D platform and advancing its pipeline from discovery into the clinic, while also securing collaborations with Gilead Sciences and Bayer. Earlier in his career, he led Pfizer’s immunoregulation department as well as external R&D innovation efforts in autoimmune and inflammatory diseases, and previously held leadership roles in Inflammation Discovery Research at Roche.

Dr. Lazar is Co-Founder and Chief Scientific Officer at Dualitas Therapeutics. Prior to Dualitas he led research groups at Genentech, Eli Lilly, and Xencor. Together with colleagues, Dr. Lazar has developed multiple technologies for optimizing antibodies and therapeutic proteins, and contributed to numerous clinical stage molecules including several approved drugs. He is an inventor of over 30 patents and has authored over 40 scientific publications in the fields of protein design, biotherapeutic engineering, and drug discovery. Dr. Lazar holds a BS in Molecular & Cell Biology with Chemistry Honors from Penn State and a PhD in Molecular & Cell Biology from UC Berkeley, and was a Jane Coffin Childs Fellow at the University of Cambridge.

Forbes Huang is Co-Founder, Chief Operating Officer and Chief Business Officer of Dualitas Therapeutics overseeing operations, business development, portfolio management, investor relations, human resources, and finance for the Company. He was previously CEO for a Novo Holdings startup (acquired by Insmed); Senior Vice President of Corporate Development at Gyroscope Therapeutics (acquired by Novartis), and Vice President of Business Development & Operations at IVERIC bio (acquired by Astellas). He began his career in investment banking at Morgan Stanley advising on biotech IPOs, M&A, and financing, and private equity investing at H.I.G. Capital. 

Forbes received his MBA from The Wharton School of the University of Pennsylvania with highest distinction as a Palmer Scholar. He is an appointed Senior Fellow with The Wharton School and served as Executive-in-Residence at the Penn Center for Innovation. He earned dual bachelor’s degrees in Finance and Economics from New York University’s Stern School of Business graduating summa cum laude.